Log in to save to my catalogue

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with...

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A726988145

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma

About this item

Full title

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma

Publisher

S. Karger AG

Journal title

Liver Cancer, 2022, Vol.11 (5), p.460

Language

English

Formats

Publication information

Publisher

S. Karger AG

More information

Alternative Titles

Full title

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A726988145

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A726988145

Other Identifiers

ISSN

2235-1795

DOI

10.1159/000525488

How to access this item